Sex bias in medicine has high costs
Women comprise only one-quarter of participants in clinical trials although they metabolise medicines differently to men
You must be signed in to read this analysis
In this article
- Body differences
- Missing women
- Clinical trials
- Women's diseases
- Missed opportunities
- A disregard for disaggregation
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.
